Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...

Primary aldosteronism is a type of high blood pressure that can be caused by tumors growing in the outer layer of the adrenal ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its Welireg oral cancer drug in patients with rare tumors that form in and around the ...

colon and adrenal gland) or wall of large vessels (celiac axis or superior mesenteric artery) † M1-specific sites defined according to Sobin and Wittekind. M: Metastasis; N: Node; T: Tumor.

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...

The adrenal glands are stimulated by ACTH to release ... Typical doses of dexamethasone used in the brain tumor patient are pharmacologic (i.e., supraphysiologic) in nature and have the potential ...

MicroRNAs (miRNAs) are endogenous small noncoding RNAs that regulate gene expression by either degrading or inhibiting the translation of mRNAs and have significant roles in the development of various ...